Sarepta Therapeutics, Inc. (SRPT) stock
SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3085% below fair value
$16.07+0.06 (+0.37%)
Close on Nov 13, 2026Market cap $1.70BP/E –Yield –
Sarepta Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sarepta Therapeutics's enterprise value was $973.31M on Nov 11, 2026, against $1.38B a year earlier. Over the last 5 years it ranged from $819.55M to $13.64B, with a median of $6.11B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $973.31M | -30.7% |
| 2025 | Dec 31, 2025 | $1.40B | -86.6% |
| 2024 | Dec 31, 2024 | $10.50B | +44.5% |
| 2023 | Dec 29, 2023 | $7.27B | -21.7% |
| 2022 | Dec 30, 2022 | $9.28B | +66.0% |
| 2021 | Dec 31, 2021 | $5.59B | -51.8% |
| 2020 | Dec 31, 2020 | $11.61B | +35.7% |
| 2019 | Dec 31, 2019 | $8.56B | +31.9% |
| 2018 | Dec 31, 2018 | $6.48B | +118.0% |
| 2017 | Dec 29, 2017 | $2.97B | +171.4% |
| 2016 | Dec 30, 2016 | $1.10B | -27.3% |
| 2015 | Dec 31, 2015 | $1.51B | +320.4% |
| 2014 | Dec 31, 2014 | $358.58M | -26.0% |
| 2013 | Dec 31, 2013 | $484.85M | -12.6% |
| 2012 | Dec 31, 2012 | $554.95M | +868.4% |
| 2011 | Dec 30, 2011 | $57.31M | -61.6% |
| 2010 | Dec 31, 2010 | $149.08M | – |
See a number that looks wrong?